Kalkinemedia

Published September 16, 2026 · Updated September 17, 2026

Optimi Health (OPTI.CN) Initiates Health Canada-Approved Phase 3 MDMA Trial Targeting ...

Read the full story at Kalkinemedia

Optimi Health Corp. · Health Canada has authorized a Phase 3 trial to evaluate synthetic MDMA HCl-assisted therapy for PTSD, with initiation targeted.